| 2922.50.07 | 00 | 3,4-Diaminophenetole dihydrogen sulfate; 2-Nitro-5-[(2,3-dihydroxy)propoxy]-￠/methylaniline; 2-Nitro-5-(2-hydroxyethoxy)-N-methylaniline; 4-(2-Hydroethoxy)-1,3-phenylenediamine dihydrochloride; 3-Methoxy-4-[(2-hydroxyethyl)amino]nitro- benzene; 4-[(2-Hydroxyethyl)amino]-3-nitrophenol; and ￠/- α-Amino-4-hydroxybenzeneacetic acid (d(-)-p-Hydroxyphenylglycine) | kg | Free | | 15.4￠/kg + 50% |
| 2922.50.10 | 00 | dl-3-(3,4-Dihydroxyphenyl)alanine; N-Ethyl-N-(2-methoxycarbonylethyl)aniline; dl-Phenylephrine base; and Carbonic acid, methyl ester, diester with 2,2'-(m-tolylamino)diethanol (Toluidine carbonate) | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.50.13 | 00 | Isoetharine hydrochloride; Isoxsuprine hydrochloride; Nylidrin hydrochloride; Phenylephrine hydrochloride; Salbutamol (Albuterol); and Terbutaline sulfate | kg | Free | | 15.4￠/kg + 47% |
| 2922.50.17 | 00 | Dermatological agents and local anesthetics | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 51.5% |
| 2922.50.19 | 00 | Guaiacol derivatives | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 79% |
| 2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924.11.00 | 00 | Acyclic amides (including acyclic carbamates) and their derivatives; salts thereof: | | | | |
| 2924.11.00 | 00 | Meprobamate (INN) | kg | Free | | 25% |
| 2924.21 | | Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: | | | | |
| 2924.21 | | Ureines and their derivatives; salts thereof: | | | | |
| 2924.21.04 | 00 | Aromatic: | | | | |
| 2924.24.00 | 00 | Ethinamate (INN) | kg | Free | | 30.5% |
| 2924.29.01 | 00 | Aromatic: | | | | |
| 2924.29.23 | 00 | 4-Aminoacetanilide; 2,2'-Oxamidobis[ethyl-3-(3,5-di-tert-butyl- 4-hydroxyphenyl)propionate]; Acetoacetsulfanilic acid, potassium salt; and N-(2,3-Dihydroxypropyl)-5-N-(2,3-dihydroxy- propyl)acetamido-N'-(2-hydroxyethyl)- 2,4,6-triiodoisophthalamide | kg | Free | | 15.4￠/kg + 58% |
| 2924.29.33 | 00 | Naphthol AS and derivatives: | | | | |
| 2924.29.43 | 00 | 3-Ethoxycarbonylaminophenyl-￠/phenylcarbamate (Desmedipham); and Isopropyl-N-(3-chlorophenyl)car- bamate (CIPC) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 40.5% |
| 2925.11.00 | 00 | Imides and their derivatives; salts thereof: | | | | |
| 2925.19.10 | 00 | Aromatic: | | | | |
| 2925.21.00 | 00 | Imines and their derivatives; salts thereof: | | | | |
| 2925.29.10 | 00 | Aromatic: | | | | |
| 2926.30 | | Fenproporex (INN) and its salts; Methadone (INN) intermediate (4-cyano-2-dimethylamino-4,4- diphenylbutane): | | | | |
| 2926.90.01 | 00 | Aromatic: | | | | |
| 2926.90.05 | 00 | 2-Amino-4-chlorobenzonitrile (5-Chloro-2- cyanoaniline); 2-Amino-5-chlorobenzonitrile; 4-Amino-2-chlorobenzonitrile; (Cyanoethyl)(hydroxyethyl)-m-toluidine; p-Cyanophenyl acetate; Phthalonitrile; and Tetrachloro-3-cyanobenzoic acid, methyl ester | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 41% |
| 2926.90.16 | 00 | [1 α(S*),3 α(Z)]-( ± )-Cyano(3-phenoxyphenyl)- methyl 3-(2-chloro-3,3,3-trifluoro-1-propenyl)- 2,2-dimethylcyclopropanecarboxylate | kg | Free | | 15.4￠/kg + 64.5% |
